Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018

SELL
$59.7 - $99.25 $262,202 - $435,906
-4,392 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$93.85 - $132.45 $98,448 - $138,940
1,049 Added 31.38%
4,392 $434,000
Q3 2017

Nov 13, 2017

SELL
$72.0 - $119.75 $32,832 - $54,606
-456 Reduced 12.0%
3,343 $400,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,799
3,799 $330,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $132M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.